PL173784B1 - Sposób wytwarzania kwasu 1-podstawionego-6-fluoro-4-okso-7-(1-piperazynylo)-1,4-dihydrochinolino-3-karboksylowego - Google Patents
Sposób wytwarzania kwasu 1-podstawionego-6-fluoro-4-okso-7-(1-piperazynylo)-1,4-dihydrochinolino-3-karboksylowegoInfo
- Publication number
- PL173784B1 PL173784B1 PL93301045A PL30104593A PL173784B1 PL 173784 B1 PL173784 B1 PL 173784B1 PL 93301045 A PL93301045 A PL 93301045A PL 30104593 A PL30104593 A PL 30104593A PL 173784 B1 PL173784 B1 PL 173784B1
- Authority
- PL
- Poland
- Prior art keywords
- substituted
- oxo
- fluoro
- dihydroquinoline
- formula
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 18
- 239000013067 intermediate product Substances 0.000 title 1
- -1 1-substituted-6-fluoro-4-oxo-7- (1-piperazinyl) -1,4-dihydroquinoline-3-carboxylic acid Chemical class 0.000 claims abstract description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract description 8
- GBUDUCWUAWUSEV-UHFFFAOYSA-K [B+3].CC([O-])=O.CC([O-])=O.CC([O-])=O Chemical compound [B+3].CC([O-])=O.CC([O-])=O.CC([O-])=O GBUDUCWUAWUSEV-UHFFFAOYSA-K 0.000 claims abstract description 8
- 239000002253 acid Substances 0.000 claims abstract description 8
- 238000010534 nucleophilic substitution reaction Methods 0.000 claims abstract description 8
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 7
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims abstract description 6
- 238000005904 alkaline hydrolysis reaction Methods 0.000 claims abstract description 6
- 238000002360 preparation method Methods 0.000 claims abstract description 6
- 150000003839 salts Chemical class 0.000 claims abstract description 6
- 229910052801 chlorine Inorganic materials 0.000 claims abstract description 5
- 125000005843 halogen group Chemical group 0.000 claims abstract description 5
- 150000004677 hydrates Chemical class 0.000 claims abstract description 5
- 125000004215 2,4-difluorophenyl group Chemical group [H]C1=C([H])C(*)=C(F)C([H])=C1F 0.000 claims abstract description 4
- 125000000753 cycloalkyl group Chemical group 0.000 claims abstract description 4
- 229910052731 fluorine Inorganic materials 0.000 claims abstract description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 15
- 150000001875 compounds Chemical class 0.000 claims description 11
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 9
- 239000011541 reaction mixture Substances 0.000 claims description 7
- 238000006467 substitution reaction Methods 0.000 claims description 7
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 4
- KPVRJEIPIYNFNT-UHFFFAOYSA-L [B+2].CC([O-])=O.CC([O-])=O Chemical compound [B+2].CC([O-])=O.CC([O-])=O KPVRJEIPIYNFNT-UHFFFAOYSA-L 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 2
- 239000012736 aqueous medium Substances 0.000 claims 1
- 238000009835 boiling Methods 0.000 claims 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 abstract description 2
- 229910052740 iodine Inorganic materials 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- 229910052796 boron Inorganic materials 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 3
- 230000000975 bioactive effect Effects 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- DGLCLBGXXHVMDM-UHFFFAOYSA-K C(C)(=O)[O-].C(C)(=O)[O-].[B+3].C(C)N1C=C(C(C2=CC(=C(C=C12)N1CCN(CC1)C(=O)OCC)F)=O)C(=O)[O-] Chemical compound C(C)(=O)[O-].C(C)(=O)[O-].[B+3].C(C)N1C=C(C(C2=CC(=C(C=C12)N1CCN(CC1)C(=O)OCC)F)=O)C(=O)[O-] DGLCLBGXXHVMDM-UHFFFAOYSA-K 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- DKAGJZJALZXOOV-UHFFFAOYSA-N hydrate;hydrochloride Chemical compound O.Cl DKAGJZJALZXOOV-UHFFFAOYSA-N 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 125000004193 piperazinyl group Chemical group 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- CQHKERVHCZAOQI-UHFFFAOYSA-K C(C)(=O)[O-].C(C)(=O)[O-].[B+3].C(C)N1C=C(C(C2=CC(=C(C=C12)Cl)F)=O)C(=O)[O-] Chemical compound C(C)(=O)[O-].C(C)(=O)[O-].[B+3].C(C)N1C=C(C(C2=CC(=C(C=C12)Cl)F)=O)C(=O)[O-] CQHKERVHCZAOQI-UHFFFAOYSA-K 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000001638 boron Chemical class 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 125000001309 chloro group Chemical class Cl* 0.000 description 1
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000000806 fluorine-19 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- OGJPXUAPXNRGGI-UHFFFAOYSA-N norfloxacin Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 OGJPXUAPXNRGGI-UHFFFAOYSA-N 0.000 description 1
- 150000004885 piperazines Chemical class 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 229910000046 scandium hydride Inorganic materials 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SI9200377A SI9200377A (en) | 1992-12-11 | 1992-12-11 | Process for the preparation of 1-substituted 6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydroquinoline-3-carboxilic acid, novel intermediate used in this process and process for its preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
PL301045A1 PL301045A1 (en) | 1994-06-13 |
PL173784B1 true PL173784B1 (pl) | 1998-04-30 |
Family
ID=20431064
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL93301045A PL173784B1 (pl) | 1992-12-11 | 1993-11-12 | Sposób wytwarzania kwasu 1-podstawionego-6-fluoro-4-okso-7-(1-piperazynylo)-1,4-dihydrochinolino-3-karboksylowego |
Country Status (13)
Country | Link |
---|---|
AT (1) | AT401648B (cs) |
CA (1) | CA2111181A1 (cs) |
CZ (1) | CZ284715B6 (cs) |
EE (1) | EE9400277A (cs) |
HR (1) | HRP931485A2 (cs) |
HU (1) | HUT75319A (cs) |
LT (1) | LT3084B (cs) |
LV (1) | LV10863B (cs) |
PL (1) | PL173784B1 (cs) |
RU (1) | RU2127270C1 (cs) |
SI (1) | SI9200377A (cs) |
SK (1) | SK140093A3 (cs) |
YU (1) | YU76593A (cs) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7452888B2 (en) * | 2002-03-27 | 2008-11-18 | Glaxo Group Limited | Quinoline derivatives and their use as 5-ht6 ligands |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE444566B (sv) | 1977-09-20 | 1986-04-21 | Bellon Labor Sa Roger | 7-dialkylamin-6-halogen-4-oxo-1,4-dihydrokinolin-3-karboxylsyra, forfarande for framstellning derav och farmaceutiskt preparat derav |
DE2747357A1 (de) | 1977-10-21 | 1979-04-26 | Bayer Ag | Substituierte pyrimidinyl(thiono) (thiol)phosphor (phosphon)-saeureester bzw. -esteramide, verfahren zu ihrer herstellung und ihre verwendung als insektizide und akarizide |
JPS5533453A (en) | 1978-08-31 | 1980-03-08 | Dainippon Pharmaceut Co Ltd | Preventive and remedy for infectious disease of fish |
JPS5762259A (en) | 1980-09-05 | 1982-04-15 | Kyorin Pharmaceut Co Ltd | Preparation of substituted quinolinecarboxylic acid derivative |
DE3308909A1 (de) | 1983-03-12 | 1984-09-13 | Bayer Ag, 5090 Leverkusen | Bakterizide mittel auf chinoloncarbonsaeure-basis |
HU198709B (en) * | 1987-04-08 | 1989-11-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing quinoline-carboxylic acid derivatives |
YU46099B (sh) * | 1987-12-31 | 1992-12-21 | Krka Tovarna Zdravil | Postopek za pripravo 1-supstituirane 6-fluoro-4-okso-7- 1-piperazinil)-1 |
DE8812756U1 (de) | 1988-09-22 | 1988-12-01 | Weinschlauch Hemü Weinhandel GmbH, 4000 Düsseldorf | Zapfschrank |
-
1992
- 1992-12-11 SI SI9200377A patent/SI9200377A/sl unknown
-
1993
- 1993-10-18 HU HU9302940A patent/HUT75319A/hu unknown
- 1993-11-12 PL PL93301045A patent/PL173784B1/pl unknown
- 1993-12-06 CZ CZ932643A patent/CZ284715B6/cs not_active IP Right Cessation
- 1993-12-07 LT LTIP1558A patent/LT3084B/lt not_active IP Right Cessation
- 1993-12-10 SK SK140093A patent/SK140093A3/sk unknown
- 1993-12-10 AT AT249793A patent/AT401648B/de not_active IP Right Cessation
- 1993-12-10 LV LVP-93-1317A patent/LV10863B/en unknown
- 1993-12-10 HR HRP931485 patent/HRP931485A2/hr not_active Application Discontinuation
- 1993-12-10 YU YU76593A patent/YU76593A/sh unknown
- 1993-12-10 CA CA 2111181 patent/CA2111181A1/en not_active Abandoned
- 1993-12-10 RU RU93054527A patent/RU2127270C1/ru active
-
1994
- 1994-11-17 EE EE9400277A patent/EE9400277A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
LT3084B (en) | 1994-11-25 |
HRP931485A2 (en) | 1995-04-30 |
ATA249793A (de) | 1996-03-15 |
SK140093A3 (en) | 1994-11-09 |
AT401648B (de) | 1996-10-25 |
YU76593A (sh) | 1996-07-24 |
CZ264393A3 (en) | 1994-07-13 |
SI9200377A (en) | 1994-06-30 |
HUT75319A (en) | 1997-05-28 |
RU2127270C1 (ru) | 1999-03-10 |
CA2111181A1 (en) | 1994-06-12 |
LV10863B (en) | 1996-08-20 |
PL301045A1 (en) | 1994-06-13 |
LTIP1558A (en) | 1994-06-15 |
HU9302940D0 (en) | 1993-12-28 |
LV10863A (lv) | 1995-10-20 |
CZ284715B6 (cs) | 1999-02-17 |
EE9400277A (et) | 1996-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0342675B1 (en) | Novel quinolonecarboxylic acid derivatives | |
EP0140116B1 (en) | A 6-fluoro-1,4-dihydro-4-oxo-7-substituted piperazinyl-quinoline-3-carboxylic acid derivative and the method for preparing the same | |
US5639886A (en) | One-pot process for the preparation of 3-quinolonecarboxylic acid derivatives | |
CA1198425A (en) | Quinolone compounds | |
NZ207239A (en) | Quinolone carboxylic acid derivatives and pharmaceutical compositions | |
HU199821B (en) | Process for production of derivatives of in 8 position substituated quinoline carbonic acid and medical compositions containing them | |
JP2520549B2 (ja) | フルオロシクロプロピルアミノアクリル酸エステル誘導体 | |
JPH0778065B2 (ja) | (6,7―置換―8―アルコキシ―1―シクロプロピル―1,4―ジヒドロ―4―オキソ―3―キノリンカルボン酸―o▲上3▼,o▲上4▼)ビス(アシルオキシ―o)ホウ素化合物及びその塩並びにその製造方法 | |
CA1339373C (en) | 6-7-disubstituted 1-cyclopropyl-1,4-dihydro-4-oxo-1,8-naphthyridine-3-c arboxylic acids | |
CZ297212B6 (cs) | Zpusob výroby derivátu kyselin 3-chinolonkarboxylových | |
PL171910B1 (pl) | S p o só b wytwarzania nowych pochodnych kw asu chinolonokarboksylow ego PL PL PL PL | |
HU187356B (en) | Process for producing quinoline-carboxylic acid derivatives | |
CS264345B2 (en) | Process for preparing quinolincarboxylic acids | |
KR100256461B1 (ko) | 삼환 화합물의 제조 방법 | |
PL173784B1 (pl) | Sposób wytwarzania kwasu 1-podstawionego-6-fluoro-4-okso-7-(1-piperazynylo)-1,4-dihydrochinolino-3-karboksylowego | |
JP2865761B2 (ja) | ベンゾ[b][1,8]ナフチリジン誘導体類およびそれらの調製 | |
CS261250B2 (en) | Method of 1-methylaminoquinolinecarboxyl acid's and its derivatives production | |
GB2043635A (en) | Quinoline derivatives | |
RU2002744C1 (ru) | Способ получени 1-замещенной 6-фтор-4-оксо-7-(1-пиперазинил)-1,4-дигидрохинолин-3-карбоновой кислоты | |
KR870000894B1 (ko) | 퀴놀론 카복실산의 제조방법 | |
JPS6185381A (ja) | 1−エチル−6,8−ジフルオロ−1,4−ジヒドロ−4−オキソ−7−ピペラジニルキノリン−3−カルボン酸誘導体の製造法 | |
SI9300192A (sl) | Postopek za pripravo 1-subst.-6-fluoro-4-okso-7-(1-piperazinil ali 4-subst.-1-piperazinil)- 1.4-dihidrokinolin-3-karboksilne kisline, nov intermediat, uporaben v tem postopku, in postopek za pripravo tega intermediata | |
JPS62294689A (ja) | キノリン−3−カルボン酸誘導体 | |
JPH0376316B2 (cs) | ||
JPS61143362A (ja) | キノリンカルボン酸誘導体 |